| Date Filed | Type | Description |
| 06/16/2023 |
4
| High Katherine A (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 2,505 shares
@ $0
Granted 11,294 options to buy
@ $61.44, valued at
$693.9k
|
|
| 06/09/2023 |
4
| High Katherine A (Director) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Granted 13,000 options to buy
@ $62.59, valued at
$813.7k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2020 |
4
| High Katherine A (Director) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Granted 15,000 options to buy
@ $59.7, valued at
$895.5k
|
|
| 05/28/2020 |
4
| High Katherine A (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 1,282 shares
@ $0
Granted 10,514 options to buy
@ $98.68, valued at
$1M
|
|
| 03/30/2020 |
4
| High Katherine A (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 139 shares
@ $0
Granted 1,285 options to buy
@ $73.05, valued at
$93.9k
|
|
| 03/30/2020 |
3
| High Katherine A (Director) has filed a Form 3 on INCYTE CORP |
| 12/17/2019 |
4
| High Katherine A (See Remarks) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Unknown transaction of 278,834 shares
@ $114.5, valued at
$31.9M
Disposed/sold 35,000 options to buy
@ $42.73, valued at
$1.5M
Disposed/sold 23,625 options to buy
@ $50.55, valued at
$1.2M
Disposed/sold 15,750 options to buy
@ $56.17, valued at
$884.7k
Disposed/sold 13,750 options to buy
@ $40.44, valued at
$556.1k
Disposed/sold 21,250 restricted stock units
@ $0 |
|
| 06/13/2019 |
4
| High Katherine A (Director) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Granted 30,000 options to buy
@ $43.52, valued at
$1.3M
|
|
| 06/13/2019 |
3
| High Katherine A (Director) has filed a Form 3 on CRISPR Therapeutics AG |
| 03/25/2019 |
4
| High Katherine A (See Remarks) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 31,653 shares
@ $113.25, valued at
$3.6M
Paid exercise price by delivering 49,561 shares
@ $113.255, valued at
$5.6M
Paid exercise price by delivering 25,993 shares
@ $113.26, valued at
$2.9M
Paid exercise price by delivering 11,184 shares
@ $113.26, valued at
$1.3M
Paid exercise price by delivering 5,367 shares
@ $113.26, valued at
$607.9k
Exercised 73,249 options to buy
@ $3.45, valued at
$252.7k
Exercised 5,840 options to buy
@ $68.45, valued at
$399.7k
Exercised 3 options to buy
@ $40.44, valued at
$121.3
Exercised 64,160 options to buy
@ $68.45, valued at
$4.4M
Exercised 41,247 options to buy
@ $40.44, valued at
$1.7M
Exercised 15,750 options to buy
@ $56.17, valued at
$884.7k
|
|
| 01/23/2019 |
4
| High Katherine A (See Remarks) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 808 shares
@ $45.08, valued at
$36.4k
Paid exercise price by delivering 683 shares
@ $45.08, valued at
$30.8k
Exercised 2,250 restricted stock units
@ $0 |
|
| 01/17/2019 |
4
| High Katherine A (See Remarks) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Granted 35,000 options to buy
@ $42.73, valued at
$1.5M
Granted 10,000 restricted stock units
@ $0 |
|
| 01/22/2018 |
4
| High Katherine A (See Remarks) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 791 shares
@ $50.55, valued at
$40k
Granted 31,500 options to buy
@ $50.55, valued at
$1.6M
Granted 9,000 restricted stock units
@ $0
Exercised 2,250 restricted stock units
@ $0 |
|
| 11/29/2017 |
4
| High Katherine A (See Remarks) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Sold 3,500 shares
@ $70.91, valued at
$248.2k
Sold 1,500 shares
@ $72.27, valued at
$108.4k
Exercised 5,000 options to buy
@ $3.45, valued at
$17.3k
|
|
| 11/06/2017 |
4
| High Katherine A (See Remarks) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Sold 5,000 shares
@ $83.3, valued at
$416.5k
Exercised 5,000 options to buy
@ $3.45, valued at
$17.3k
|
|
| 09/28/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/21/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/16/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/19/2016 |
4
| High Katherine A (See Remarks) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Sold 9,500 shares
@ $60.33, valued at
$573.1k
Sold 500 shares
@ $61.2, valued at
$30.6k
|
|
| 08/17/2016 |
4
| High Katherine A (See Remarks) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Sold 5,000 shares
@ $61.88, valued at
$309.4k
Sold 1,458 shares
@ $62.79, valued at
$91.5k
Sold 3,342 shares
@ $63.94, valued at
$213.7k
Sold 200 shares
@ $64.59, valued at
$12.9k
|
|
| 08/12/2016 |
4
| High Katherine A (See Remarks) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Sold 1,890 shares
@ $60, valued at
$113.4k
|
|
| 08/08/2016 |
4
| High Katherine A (See Remarks) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Sold 100 shares
@ $60, valued at
$6k
Sold 400 shares
@ $60.3, valued at
$24.1k
|
|
| 08/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/27/2016 |
4
| High Katherine A (See Remarks) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Sold 10,000 shares
@ $54, valued at
$540k
|
|